What volume of magnesium citrate solution (1.745 g per 30 mL) should be given to treat constipation?

Magnesium Citrate Dosing for Constipation

For adults and children ≥12 years, give 195-300 mL (6.5-10 fl oz) of magnesium citrate solution as a single daily dose or in divided doses, with a maximum of 300 mL (10 fl oz) in 24 hours 1.

Age-Specific Dosing Algorithm

The FDA-approved dosing for magnesium citrate 1.745 g/30 mL (1.745 g per fl oz) is stratified by age 1:

Adults and Children ≥12 years:

• Dose: 195-300 mL (6.5-10 fl oz)
• Maximum: 300 mL in 24 hours
• Can be given as single daily dose or divided doses

Children 6 to <12 years:

• Dose: 90-210 mL (3-7 fl oz)
• Maximum: 210 mL in 24 hours

Children 2 to <6 years:

• Dose: 60-90 mL (2-3 fl oz)
• Maximum: 90 mL in 24 hours

Children <2 years:

• Consult physician before use

Clinical Context and Positioning

While the 2023 AGA-ACG guidelines recommend magnesium oxide (not magnesium citrate) as a conditional recommendation for chronic idiopathic constipation 2, magnesium citrate remains widely used for acute constipation relief and bowel preparation. The guidelines prioritize PEG as first-line osmotic therapy with strong evidence, followed by magnesium oxide with very low quality evidence 2.

Key implementation points:

• Magnesium citrate typically produces bowel movement in 0.5-6 hours 1
• Instruct patients to shake well before use and drink a full 8-ounce glass of liquid with each dose 1
• Large retrospective data (n=19,173) shows 98.94% adequacy rates for constipation management 3

Critical Safety Considerations

Avoid magnesium citrate in patients with renal insufficiency due to hypermagnesemia risk 2. This is the most important contraindication to screen for before prescribing any magnesium-based laxative.

Practical Dosing Strategy

Start with the lower end of the dosing range (6.5 fl oz/195 mL for adults) and titrate upward if needed, as the guidelines suggest starting at lower doses for magnesium-based agents 2. For pediatric patients, the reduced gastrointestinal transit time has been demonstrated even at 4 mL/kg doses 4, supporting efficacy across the recommended range.